The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes
Journal of Endocrinology and Metabolism · 2026-06 · 16 (3) · 142-147
DOI: 10.14740/jem1637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology and Metabolism, 2026-06. Verfasst von Masataka Kusunoki und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kusunoki, M., Hisano, F., Matsuda, S., Kunitsu, K., Miyanaga, D., Kusunoki, M., Tsutsumi, K., & Miyata, T. (2026). The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes. Journal of Endocrinology and Metabolism, 16(3), 142-147. https://doi.org/10.14740/jem1637
Vancouver
Kusunoki M, Hisano F, Matsuda S, Kunitsu K, Miyanaga D, Kusunoki M, et al. The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes. Journal of Endocrinology and Metabolism. 2026;16(3):142-147. doi:10.14740/jem1637
BibTeX
@article{Kusunoki2026,
author = {Kusunoki, Masataka and Hisano, Fumiya and Matsuda, Shin-ichi and Kunitsu, Kohei and Miyanaga, Daijiro and Kusunoki, Masaaki and Tsutsumi, Kazuhiko and Miyata, Tetsuro},
title = {The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes},
journal = {Journal of Endocrinology and Metabolism},
year = {2026},
volume = {16},
number = {3},
pages = {142--147},
doi = {10.14740/jem1637}
}
EUVIMED